Rating History for Centessa Pharmaceuticals (CNTA) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/26/2023 | Matthew Harrison | Upgrade | Equalweight (Underweight) |
8.00 (4.00) |
6.64 (9.40) |
41.57% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
